Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Camlin Fine SciencesNSE:CAMLINFINE -1.98%62 EV-to-EBIT is 75.03 as of Jul. 23, 2026, which is 303% above its 10-year median of 18.63. GuruFocus rates NSE:CAMLINFINE with a GF Score™ of 62/100 and a GF Value™ of ₹143.25 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,239 Chemicals companies, Camlin Fine Sciences ranks worse than 89.83% on this metric.
Camlin Fine Sciences (NSE:CAMLINFINE) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Camlin Fine Sciences's Enterprise Value for the quarter that ended in Mar. 2026 was ₹24,301 Mil.
Camlin Fine Sciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹387 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Camlin Fine Sciences EV-to-EBIT Related Terms
Camlin Fine Sciences EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Camlin Fine Sciences's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CAMLINFINE vs LIN, SHW, ECL: EV-to-EBIT Comparison
For the Specialty Chemicals subindustry, Camlin Fine Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Camlin Fine Sciences EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Camlin Fine Sciences's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Camlin Fine Sciences's EV-to-EBIT falls into.
Camlin Fine Sciences's current Enterprise Value is ₹29,031 Mil.
Camlin Fine Sciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹387 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Camlin Fine Sciences (NSE:CAMLINFINE) has a EV-to-EBIT of 75.03 as of Jul. 23, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Camlin Fine Sciences and its competitors. This is 303% above median its historical median of 18.63. According to the industry distribution chart, Camlin Fine Sciences ranks #1113 out of 1239 companies in the Chemicals industry, placing it in the top 89.8%.
Is Camlin Fine Sciences' EV-to-EBIT too high?
Camlin Fine Sciences' current EV-to-EBIT of 75.03 is 303% above median its 10-year median of 18.63. The Chemicals industry median EV-to-EBIT is 17.49. Camlin Fine Sciences' value of 75.03 is 329% above this industry median. Based on the distribution chart, Camlin Fine Sciences ranks #1113 out of 1239 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Camlin Fine Sciences has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Camlin Fine Sciences' EV-to-EBIT compare to LIN and SHW?
According to the Chemicals industry distribution chart, Camlin Fine Sciences ranks #1113 out of 1239 companies for EV-to-EBIT. This places Camlin Fine Sciences in the lower half of its industry. The industry median EV-to-EBIT is 17.49. Camlin Fine Sciences' value of 75.03 is 329% above this benchmark. While the company's 10-year median is 18.63 vs. the industry median of 17.49, Camlin Fine Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.49, based on 1,239 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Camlin Fine Sciences's current EV-to-EBIT of 75.03 is 329% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Camlin Fine Sciences and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Camlin Fine Sciences's current EV-to-EBIT is 75.03, which is 303% above median its own 10-year median of 18.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camlin Fine Sciences stock overvalued right now?
Based on GuruFocus' analysis, Camlin Fine Sciences (NSE:CAMLINFINE) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹143.25, compared to a current price of ₹120.61 — trading 15.8% below its estimated fair value. The current EV-to-EBIT is 75.03, which is 303% above median its 10-year median of 18.63 and 329% above the Chemicals industry median of 17.49. Camlin Fine Sciences' overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Camlin Fine Sciences (NSE:CAMLINFINE), the current EV-to-EBIT is 75.03 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Camlin Fine Sciences (NSE:CAMLINFINE) Overvalued in 2026?
Based on GuruFocus' analysis, Camlin Fine Sciences stock appears to be undervalued.
The current stock price of ₹120.61 is trading 15.8% below its estimated GF Value™ of ₹143.25.
GuruFocus considers Camlin Fine Sciences to be Modestly Undervalued.
Key valuation signals for NSE:CAMLINFINE:
EV-to-EBIT: 75.03 (303% above median its 10-year median of 18.63)
GF Value™: ₹143.25 vs. price of ₹120.61 (15.8% below fair value)
Industry Position: 329% above the Chemicals median (#1113 of 1239)
No single metric tells the full story. See the NSE:CAMLINFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.
62GF Score
Get the complete analysis for NSE:CAMLINFINE
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CAMLINFINE has been successfully added to your 
